Franklin Resources’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-133,410
| Closed | -$3.38M | – | 2914 |
|
|
2024
Q3 | $3.38M | Sell |
133,410
-8,341
| -6% | -$211K | ﹤0.01% | 1521 |
|
|
2024
Q2 | $3.59M | Buy |
141,751
+1,246
| +0.9% | +$31.6K | ﹤0.01% | 1456 |
|
|
2024
Q1 | $3.57M | Buy |
140,505
+6,894
| +5% | +$175K | ﹤0.01% | 1492 |
|
|
2023
Q4 | $3.03M | Buy |
133,611
+19,276
| +17% | +$437K | ﹤0.01% | 1262 |
|
|
2023
Q3 | $2.13M | Sell |
114,335
-14,968
| -12% | -$279K | ﹤0.01% | 1370 |
|
|
2023
Q2 | $3.36M | Hold |
129,303
| – | – | ﹤0.01% | 1232 |
|
|
2023
Q1 | $3.71M | Buy |
129,303
+15,649
| +14% | +$449K | ﹤0.01% | 1176 |
|
|
2022
Q4 | $3.36M | Buy |
113,654
+41
| +0% | +$1.21K | ﹤0.01% | 1224 |
|
|
2022
Q3 | $2.7M | Buy |
113,613
+36,751
| +48% | +$875K | ﹤0.01% | 1252 |
|
|
2022
Q2 | $1.72M | Sell |
76,862
-2,450
| -3% | -$54.7K | ﹤0.01% | 1402 |
|
|
2022
Q1 | $1.99M | Buy |
79,312
+14,420
| +22% | +$362K | ﹤0.01% | 1415 |
|
|
2021
Q4 | $2.33M | Buy |
64,892
+17,500
| +37% | +$627K | ﹤0.01% | 1455 |
|
|
2021
Q3 | $2.02M | Hold |
47,392
| – | – | ﹤0.01% | 1449 |
|
|
2021
Q2 | $2.05M | Hold |
47,392
| – | – | ﹤0.01% | 1352 |
|
|
2021
Q1 | $1.93M | Buy |
47,392
+10,392
| +28% | +$424K | ﹤0.01% | 1345 |
|
|
2020
Q4 | $1.68M | Sell |
37,000
-21
| -0.1% | -$951 | ﹤0.01% | 1320 |
|
|
2020
Q3 | $1.31M | Buy |
37,021
+21
| +0.1% | +$743 | ﹤0.01% | 1323 |
|
|
2020
Q2 | $1.35M | Buy |
+37,000
| New | +$1.35M | ﹤0.01% | 1216 |
|